Browse Guides  internal medicine  haematology  anticoagulation

Warfarin

Starting treatment
Indications
Dosing and monitoring
Complications
Follow-up
Follow-up

Monitor the following patients closely - they are at increased risk of having a major bleed 
  • high therapeutic range  b
  • supratherapeutic INR ( > 4.5)  a b
  • recently started warfarin  a
  • old age  a
  • arterial disease  a
  • co-morbid conditions  b (stroke, serious heart, liver or renal disease) 
  • previous GI bleed  a
  • on NSAIDs   b

Why?

High anticoagulation and recent onset of warfarin increase the risk of major bleeding

Patient Prognostic Factor Outcome CER RR
(95% CI)
NNF+
(95% CI)
elderly on anticoagulation b INR range 3.0 - 4.0
independent
severe bleed
at 2-3 years
9.8% 1.55
(1.17 to 2.06)
19
(10 to 63)
anticoagulation a INR > 4.5
independent
major bleed
at 9 months
1.0% 5.96
(3.68 to 9.67)
20
(11 to 37)
  < 90 days since commencing therapy
independent
major bleed
at 9 months
1.0% 2.5
(1.4 to 3.3)
65
(43 to 250)
  aged 70 or more
independent
major bleed
at 9 months
0.7% 1.69
(1.21 to 2.37)
140
(72 to 470)
  arterial disease requiring anticoagulation
independent
major bleed
at 9 months
1.0% 1.72
(1.17 to 2.54)
140
(64 to 580)
 

Expiry date: May 2003
Levels of Evidence used in grading these guides

With thanks to Drs. David Keeling, John Reynolds, David Sackett, Sharon Straus and Alan Townsend 
for use of their anticoagulation guide on which this one is based.

Author   CM   Ball
Reviewer   A   Gallus
CAT Writer   CM   Ball